One study of 30 patients on nasal glutathione dosed at either 300mg or 600mg daily in three divided doses vs placebo over a three month period found significant improvement in UPDRS scores in the treatment arms over placebo while other measures of toxicity such as cell counts, liver enzymes, creatinine, blood urea nitrogen, and urinalysis were not significantly different between placebo and treatment groups
The absence of controlled human safety data, combined with product-quality and copper-exposure uncertainties, means the risk-benefit calculation cannot be made responsibly at home
2021 Nov 26:28:101177
Therefore, a bypassing key, i.e., an activated azygos vein as a rescuing pathway, avoiding both the lung and liver and also noted in BuddChiari syndrome (i.e., suprahepatic occlusion of the inferior caval vein) ( BPC 157s endothelial effects and its function as a bypassing key (Sikiric et al., 2018) are strongly supported by its interaction with the nitric oxide (NO) system (for a review, see Sikiric et al., 2014)
